CLDX
Price
$16.84
Change
+$0.90 (+5.65%)
Updated
Apr 11 closing price
Capitalization
1.12B
18 days until earnings call
MLTX
Price
$34.90
Change
+$0.93 (+2.74%)
Updated
Apr 11 closing price
Capitalization
2.21B
24 days until earnings call
Ad is loading...

CLDX vs MLTX

Header iconCLDX vs MLTX Comparison
Open Charts CLDX vs MLTXBanner chart's image
Celldex Therapeutics
Price$16.84
Change+$0.90 (+5.65%)
Volume$805.58K
Capitalization1.12B
MoonLake Immunotherapeutics
Price$34.90
Change+$0.93 (+2.74%)
Volume$428.81K
Capitalization2.21B
CLDX vs MLTX Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. MLTX commentary
Apr 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and MLTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 14, 2025
Stock price -- (CLDX: $16.84 vs. MLTX: $34.90)
Brand notoriety: CLDX and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 99% vs. MLTX: 104%
Market capitalization -- CLDX: $1.12B vs. MLTX: $2.21B
CLDX [@Biotechnology] is valued at $1.12B. MLTX’s [@Biotechnology] market capitalization is $2.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CLDX is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 3 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • CLDX’s TA Score: 3 bullish, 4 bearish.
  • MLTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than CLDX.

Price Growth

CLDX (@Biotechnology) experienced а +6.72% price change this week, while MLTX (@Biotechnology) price change was -6.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.26%. For the same industry, the average monthly price growth was -16.13%, and the average quarterly price growth was -17.16%.

Reported Earning Dates

CLDX is expected to report earnings on Aug 07, 2025.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+0.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.21B) has a higher market cap than CLDX($1.12B). CLDX YTD gains are higher at: -33.360 vs. MLTX (-35.549). MLTX has higher annual earnings (EBITDA): -141.71M vs. CLDX (-191.9M). CLDX has more cash in the bank: 725M vs. MLTX (448M). MLTX has less debt than CLDX: MLTX (2.83M) vs CLDX (3.81M). CLDX has higher revenues than MLTX: CLDX (7.02M) vs MLTX (0).
CLDXMLTXCLDX / MLTX
Capitalization1.12B2.21B51%
EBITDA-191.9M-141.71M135%
Gain YTD-33.360-35.54994%
P/E RatioN/AN/A-
Revenue7.02M0-
Total Cash725M448M162%
Total Debt3.81M2.83M135%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXMLTX
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
55%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
57%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 6 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
58%
View a ticker or compare two or three
Ad is loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.401.38
+5.52%
GameStop Corp
AAPL198.157.73
+4.06%
Apple
BTC.X85287.1100001882.265600
+2.26%
Bitcoin cryptocurrency
SPY533.949.36
+1.78%
SPDR® S&P 500® ETF
TSLA252.31-0.09
-0.04%
Tesla

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
+5.65%
BEAM - CLDX
50%
Loosely correlated
+5.74%
DNLI - CLDX
50%
Loosely correlated
+1.60%
ATXS - CLDX
47%
Loosely correlated
-0.49%
NTLA - CLDX
47%
Loosely correlated
+9.45%
KYMR - CLDX
47%
Loosely correlated
+7.68%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+2.74%
XENE - MLTX
43%
Loosely correlated
+2.18%
CLDX - MLTX
41%
Loosely correlated
+5.65%
DNLI - MLTX
40%
Loosely correlated
+1.60%
IDYA - MLTX
39%
Loosely correlated
+6.21%
RGNX - MLTX
38%
Loosely correlated
+8.87%
More